Specialty Amines Market Outlook:
Specialty Amines Market size was over USD 9.89 billion in 2025 and is projected to reach USD 16.26 billion by 2035, growing at around 5.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of specialty amines is evaluated at USD 10.34 billion.
The rising advancement in pharmaceutical industries globally will exponentially help the specialty amines market to grow in the upcoming years. According to the data provided by the Congressional Budget Office of the U.S., compared to the preceding eleven years, the number of new pharmaceuticals licensed for sale climbed by 60% between 2010 and 2021, reaching a peak of 59 new drugs approved in 2018.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of specialty amines is evaluated at USD 10.34 billion.
The global specialty amines market size was worth over USD 9.89 billion in 2025 and is poised to grow at a CAGR of over 5.1%, reaching USD 16.26 billion revenue by 2035.
North America specialty amines market will hold more than 38% share by 2035, driven by increasing use of raw materials in pharmaceutical industries.
Key players in the market include BASF SE, Air Products and Chemicals Inc., Arkema Group, The Dow Chemical Company, BorsodChem MCHZ, Eastman Chemical Company, Alkyl Amines Chemicals Ltd., Huntsman Corporation, Ascend Performance Materials LLC, SABIC, Solvay, Koei Chemical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Akzo Nobel N.V., INEOS Group Limited.
